Figure 5
From: TCL1A expression delineates biological and clinical variability in B-cell lymphoma
Heat map showing genes coregulated with variable expression of TCL1A oncogene in chronic lymphocytic leukemia (98 cases). Cases with stronger TCL1A expression show increased expression of coregulated pathways, such as B-cell receptor genes. Cases with weaker TCL1A expression have an NF-κB target-gene signature.
